UNTITLED LETTER
Wickliffe Pharmaceutical IncFDA UNTITLED_LETTER - Wickliffe Pharmaceutical Inc - September 07, 2023
Discuss this record with AI
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.
Record Details
This UNTITLED LETTER record concerns Wickliffe Pharmaceutical Inc, with an inspection on September 7, 2023, issued by the Division of Pharmaceutical Quality Operations I, covering drugs.
Open in Dashboard
ID · 2a133e07-0650-4846-9910-fe6b849886c9
Violation Codes10
21 U.S.C. 352(f)(1)FD&C Act 360b(a)(4)FD&C Act 360b(a)(5)21 CFR 530FD&C Act 512FD&C Act 502(f)(1)FD&C Act 501(a)(2)(B)21 CFR 211.165(a)21 CFR 211.100(a)21 CFR 211.113(b)
Full citation text and observation details available on the Dashboard.